Reports of cases of mycobacterial infections after SCT are rare. We report a 30-year-old female with a cutaneous infection of Mycobacterium fortuitum 30 months after allogeneic bone marrow transplantation for acute lymphoblastic leukemia. The patient was successfully treated with surgical debridement followed by oral minocycline and clarithromycin. Mycobacterial infections should be considered in SCT patients with undiagnosed refractory chronic cutaneous infection, and surgical debridement is useful for the diagnosis and treatment of such infections. Bone Marrow Transplantation (2001) 28, 709-711.
Recipients of stem cell transplantation (SCT) have severely impaired cell-mediated immunity as a result of their underlying disease, pre-transplant chemotherapy and radiation, graft-versus-host disease (GVHD) and its treatment. However, Mycobacterium infection after SCT is very rare. We report a case of subcutaneous infection by Mycobacterium fortuitum 30 months after allogeneic bone marrow transplantation (BMT).
Case report
A 30-year-old woman was diagnosed as having acute lymphoblastic leukemia (ALL) in March 1995. She received induction chemotherapy consisting of doxorubicin (ADR), cyclophosphamide (CPM), l-asparaginase (ASP) and prednisolone (PSL). She obtained complete remission (CR) in May 1995, but relapsed 6 months later. Reinduction chemotherapy was given and after a second CR was obtained she was referred to our hospital for allogeneic BMT. She received a conditioning regimen consisting of busulfan (4 mg/kg on days −7, −6), cyclophosphamide (60 mg/kg on days −5, −4) and total body irradiation (10 Gy) followed by BMT from an HLA-matched unrelated donor. GVHD prophylaxis consisted of short-term methotrexate and cyclosporine. Acute GVHD, mainly affecting the liver and gastrointestinal tract, developed, for which the patient received steroids. However, since no clinical improvement was observed the cyclosporine was replaced by tachrolimus (FK506). Six months after BMT she received ganciclovir because of cytomegalovirus (CMV) retinitis. One year after BMT she experienced macroscopic hematuria, which resolved after the administration of ribavirin, after which prednisolone at a dose of 15 mg was continued for chronic GVHD.
In December 1998, erythematous and indurated skin lesions on her left arm were noted and cefdinir was given orally but was not effective. Fine needle aspiration cytology failed to show recurrent ALL or any microbial organism. Since the lesions failed to respond a sporotoricosis infection was suspected and the antibiotics were changed to itraconazole after which the lesion became harder and less inflamed but did not disappear. Subsequently, a wide surgical excision was performed in August 1999. Histological examination of the excised tissue showed acid-fast bacilli which were cultured and identified as Mycobacterium fortuitum by a DNA-DNA hybridization method (DDH mycobacteria, Kyokuto, Japan). The patient received minocycline and clarithromycin and the ulcer resolved 3 months later.
Discussion
Mycobacterial infections are common in patients with cellmediated immunodeficiencies such as acquired immunodeficiency syndrome (AIDS). 1 Reports of mycobacterial infections in recipients of renal transplants suggest an increased incidence of mycobacterial infections, especially in extra-pulmonary sites. 2 However, mycobacterial infections after SCT are rarely reported. [3] [4] [5] [6] [7] Navari et al 3 reported seven cases in 682 patients with leukemia who received allogeneic BMT, of which four were pulmonary and three were extra-pulmonary infections with M. tuberculosis or atypical mycobacteria. Kurzrock et al 4 reported three patients (3.3%) with mycobacterial pulmonary infections in 90 allogeneic BMT recipients with hematological malignancies or aplastic anemia. Roy et al 5 reported nine cases (0.6%) of mycobacterial infections in 1486 allogeneic BMT recipients and two in 755 autograft recipients over a 20-year period. To date, seven patients with M. fortuitum infection after SCT have been reported (Table 1) , of whom five were allograft recipients. M. fortuitum is a saprophyte whose natural habitat includes soil, water and dust and it causes a wide variety of infections. In a series of 125 cases reported by Wallace et al, 6 34 patients (27%) had primary cutaneous infections and other infections included pneumonia, prosthetic valve endocarditis, keratitis and catheterrelated infections. Although five of eight patients receiving stem cell transplantation had M. fortuitum cultured from blood or their central venous catheter tunnel, cutaneous infection by this organism should be considered in the differential diagnosis. Although the interval between BMT and M. fortuitum infection has been reported to be within 6 months, our patient developed a cutaneous infection 30 months after BMT, which may have been because she had received long-term prednisolone for the management of chronic GVHD and her immunosuppressive state had continued.
The major problem in the management of mycobacterial infection is that these mycobacteria are ubiquitous environmental organisms and infections occur in heavily immunosuppressed patients. Recognition of mycobacterial infections in SCT patients can be difficult, because these patients are severely immunosuppressed and often neutropenic, which may mask the febrile response and obscure the granulomatous reaction to infection. Moreover, mycobacterial infections present with varied and nonspecific manifestations and the isolation of mycobacteria often requires prolonged and specific culture techniques. Therefore, the suspicion of mycobacterial infection is important in the clinical management of patients.
Successful treatment of mycobacterium is rarely achieved by antimicrobial chemotherapy alone and surgical debridement is often necessary. We successfully treated a patient with surgical debridement followed by oral administration of minocyclin and clarithromycin.
In conclusion, mycobacterial infections should be con- sidered in SCT patients who experience undiagnosed refractory chronic cutaneous infections, and surgical debridement is useful in the diagnosis and treatment of cutaneous mycobacterial infection.
